Biotechnology Stocks I Performance Guide: PTC Therapeutics, Inc. (PTCT)
PTCT has no dividends
Table and Chart of PTCT Performance
See what a $1,000 investment in PTCT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| PTCT Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $16.97 |
| End Date | Dec-01-2023 |
| End Price | $23.99 |
| # Prices | 121 |
| Min Date | Jul-29-2016 |
| Min Price | $5.97 |
| Max Date | Feb-27-2015 |
| Max Price | $71.33 |
| Total Return | 41.37% |
| Annualized Return | 3.49% |
| Current Value of $1,000 Purchase | $1,414 |
| Number Returns | 7,260 |
| Average Return | 72.81% |
| Number Profitable Returns | 4,527 |
| Percent Profitable Returns | 62.36% |
| Number Unprofitable Returns | 2,733 |
| Percent Unprofitable Returns | 37.64% |
| Profitable to Unprofitable Returns Ratio | 1.66 |
| PTCT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,810,360,000 | Price to Sales | 2.27 |
| Earnings per Share | $-8.6700 |
| PE Ratio | None |
| PE to Growth Ratio | 0.81 |
| Price to Book | 1743.27 |
| PRICE DATA | |
| 52 Week High | $59.84 |
| 52 Week Low | $17.53 |
| Analyst Target Price | $28.08 |
| 50-Day Moving Average | $21.23 |
| 200-Day Moving Average | $38.63 |
| FINANCIAL DATA | |
| Revenue per Share | $10.77 |
| Revenue | $798,178,000 |
| Profit Margin | -80.4% |
| Return on Equity | -77.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
PTCT Compare Returns with S&P 500
PTCT Trendline Chart